These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21655661)

  • 21. Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection.
    Pichler M; Beckendorf J; Winter E; Kleinert R; Kniepeiss D; Hoefler G
    Transplantation; 2010 Mar; 89(6):749-55. PubMed ID: 19997059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morbidity and mortality after heart transplanation].
    Rebocho MJ; Aguiar C; Queiroz e Melo J
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():67-74. PubMed ID: 11409076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
    Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
    Fernández FG; Jaramillo A; Ewald G; Rogers J; Pasque MK; Mohanakumar T; Moazami N
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S255-61. PubMed ID: 15993782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
    Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
    J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The contribution of pathology sections to the Italian Heart Transplant Project in the first 5 years of its activities (1985-1990)].
    Gallo P; Agozzino L; Arbustini E; Baroldi G; Bartoloni G; Bonacina E; Bosman C; Catani G; Cocco P; Di Giola C
    G Ital Cardiol; 1992 Jul; 22(7):843-53. PubMed ID: 1473659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
    Kubo SH; Naftel DC; Mills RM; O'Donnell J; Rodeheffer RJ; Cintron GB; Kenzora JL; Bourge RC; Kirklin JK
    J Heart Lung Transplant; 1995; 14(3):409-18. PubMed ID: 7654724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection.
    Yamani MH; Cook DJ; Rodriguez ER; Thomas DM; Gupta S; Alster J; Taylor DO; Hobbs R; Young JB; Smedira N; Starling RC
    J Heart Lung Transplant; 2006 Nov; 25(11):1283-9. PubMed ID: 17097490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients.
    Albat B; Missov E; Serre I; Baldet P; Chaptal PA
    Minerva Cardioangiol; 1995 Oct; 43(10):435-8. PubMed ID: 8819811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of recalcitrant cardiac allograft rejection with methotrexate.
    Costanzo-Nordin MR; Grusk BB; Silver MA; Sobotka PA; Winters GL; O'Connell JB; Pifarré R; Robinson JA
    Circulation; 1988 Nov; 78(5 Pt 2):III47-57. PubMed ID: 3052918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
    Foerster A; Simonsen S; Frøysaker T
    APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.